Welcome to our dedicated page for Aimei Health Technology Co., Ltd. SEC filings (Ticker: AFJKU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Aimei Health Technology Co., Ltd.'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Aimei Health Technology Co., Ltd.'s regulatory disclosures and financial reporting.
Mizuho Financial Group reports beneficial ownership of 550,600 common shares of Aimei Health Technology, representing 9.0% of the outstanding class. The filing states Mizuho has sole voting and dispositive power over these shares and that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
The filing is made by the parent holding company and discloses that related entities (Mizuho Bank, Mizuho Americas LLC) may be deemed indirect beneficial owners through a wholly owned broker-dealer subsidiary.
W. R. Berkley Corporation and its subsidiary Berkley Insurance Company report beneficial ownership of 425,361 ordinary shares of Aimei Health Technology Co., Ltd (ordinary shares, $0.0001 par). That stake represents 6.9% of the company’s outstanding shares based on the issuer’s publicly reported total of 6,121,733 shares. The filing shows shared voting and shared dispositive power over the 425,361 shares rather than sole control.
The statement notes the securities are held in the ordinary course of business and were not acquired to change or influence control of the issuer. Reporting persons are organized in Delaware and list a Greenwich, CT address for their principal business office.